To study whether the association of chemotherapy with the prognosis was independent from the immune markers in the different nodal stage and tumor stage patient groups, we performed multivariate Cox’s regression analyses (adjusted for the immune markers CCL2, CD68, and CD163). Here, CCL2 is linked to neoplasm.